FUJIFILM THE EXTENSION OF ITS FILL FINISH SERVICES TO INCLUDE RECOMBINANT PROTEIN ASEPTIC FILLING MARKET
January 15, 2019
FUJIFILM has announced the extension of its Fill/Finish services to include cGMP aseptic filling of recombinant proteins.
These services will be added to FUJIFILM Diosynth Biotechnologies (FDB) portfolio of services.
FDB, a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant biopharmaceuticals and gene therapies,
will extend its services to include aseptic filling of recombinant proteins with the addition of segregated state of the art technologies complimenting existing capabilities in fiscal year ending March 2021.
Last May 2018 FDB had announced its entry into the gene therapy fill finish space.
These extended Fill/Finish services will be provided from FDB’s College Station, Texas location.
Press Center | FUJIFILM USA
https://www.fujifilmusa.com/press/news/display_news?newsID=881574
Fujifilm to Introduce Automatic Aseptic Filling System in US Bio CDMO Hub
Fujifilm said on January 15 that it will install a fully automated aseptic filling system in the production facilities of its subsidiary Fujifilm Diosynth Biotechnologies in Texas,
with a view to boosting its contract development and manufacturing organization (CDMO)
PHARMA JAPAN